AMRX Amneal Pharmaceuticals, Inc.
$17.01▲ +0.83%
Healthcare
Other
After hours
$17.01▲ +0.00%
Sep 11, 7:30 PM ET
Volume 1.13M
Avg Volume (10D) 1.67M
Key Metrics & Fundamentals
Market Cap
$5.92B
P/E Ratio
35.4
Div Yield
–%
52W Range
9.49 - 19.26
% vs 50 MA
-4.18%
% vs 200 MA
17.47%
RSI-14
41.7
MACD Histogram
-0.1200
Beta (1Y vs SPY)
0.65
Free Cash Flow
-$143.99M
Gross Rev
$796.20M
Gross Profit
$334.51M
EBITDA
$194.43M
COGS
$461.69M
Operating Exp
$188.53M
Operating Income
$145.98M
EBIT
$145.98M
Pretax Income
$70.99M
Net Income
$57.66M
EPS (Diluted)
0.18
Price & Volume History
Loading chart…
Recent News
Does Amneal’s Post‑Earnings Shelf Registration Reshape the Bull Case for Amneal Pharmaceuticals (AMRX)?
Simply Wall St. · Sep 5, 2026 7:06 AM
Amneal Pharmaceuticals (AMRX) Bets Big On Biosimilars While Wall Street Retreats
Insider Monkey · Sep 4, 2026 6:48 PM
Amneal Pharmaceuticals (AMRX) Stock Sees Modest Fair Value Lift On Launch Optimism
Simply Wall St. · Sep 4, 2026 4:13 PM
Generic Pharmaceuticals Stocks Q2 Results: Benchmarking Amneal (NASDAQ:AMRX)
StockStory · Sep 3, 2026 2:07 PM
JAZZ Secures FDA Nod for Expanded Use of Ziihera in Gastric Cancer
Zacks · Aug 26, 2026 4:29 PM
SYRE Stock Sinks After Mixed SKYWAY Study Data in Rheumatoid Arthritis
Zacks · Aug 26, 2026 4:10 PM
1 Stock Under $50 with Solid Fundamentals and 2 Facing Challenges
StockStory · Aug 26, 2026 11:47 AM
Here's Why You Should Add ACET Stock to Your Portfolio Now
Zacks · Aug 24, 2026 2:09 PM
Acadia Gets European Commission Nod for Daybu in Rett Syndrome
Zacks · Aug 24, 2026 2:04 PM
Are Medical Stocks Lagging Bioventus (BVS) This Year?
Zacks · Aug 24, 2026 1:40 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See AMRX's money flow as a full page
Social Sentiment
Avg -0.80 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.